APOE dependent-association of PPAR-γ genetic variants with Alzheimer's disease risk

Neurobiology of Aging

Volumn 32, Issue 3, 2011, Pages 547.e1-547.e6

  Combarros, Onofre ^a   Rodríguez Rodríguez, Eloy ^a   Mateo, Ignacio ^a   Vázquez Higuera, José Luis ^a   Infante, Jon ^a   Berciano, José ^a   Sánchez Juan, Pascual ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Alzheimer's disease; APOE; Peroxisome proliferator activated receptor ; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

EID: 79952902540     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.07.004     Document Type: Article

References (22)

1. Chinetti G., Lestavel S., Bocher V., Remaley A.T., Neve B., Torra I.P., Teissier E., Minnich A., Jaye M., Duverger N., Brewer H.B., Fruchart J.C., Clavey V., Staels B. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med. 2001, 7:53-58.
2. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J. Neurosci. 2000, 20:558-567.
3. Gong J.S., Kobayashi M., Hayashi H., Zou K., Sawamura N., Jujita S.C., Yanagisawa K., Michikawa M. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J. Biol. Chem. 2002, 277:29919-29926.
4. Hamilton G., Proitsi P., Jehu L., Morgan A., Williams J., OóDonovan M.C., Owen M.J., Powell J.F., Lovestone S. Candidate gene association study of insulin signaling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2007, 144B:508-516.
5. Helisalmi S., Tarvainen T., Vepsäläinen S., Koivisto A.M., Hiltunen M., Soininen H. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease. Neurosci. Lett. 2008, 441:233-236.
6. Heneka M.T., Landreth G.E. PPARs in the brain. Biochim. Biophys. Acta 2007, 1771:1031-1045.
7. Kaltschmidt B., Uherek M., Volk B., Baeuerle P.A., Kaltschmidt C. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:2642-2647.
8. Koivisto A.M., Helisalmi S., Pihlajamäki J., Hiltunen M., Koivisto K., Moilanen L., Kuusisto J., Helkala E.L., Hänninen T., Kervinen K., Kesäniemi Y.A., Laakso M., Soininen H. Association analysis of peroxisome proliferators-activated receptor gamma polymorphisms and late onset Alzheimer's disease in the Finnish population. Dement. Geriatr. Cogn. Disord. 2006, 22:449-453.
9. Landreth G., Jiang Q., Mandrekar S., Heneka M. PPARγ agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 2008, 5:481-489.
10. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 1984, 24:939-944.
11. Ophir G., Amariglio N., Jacob-Hirsch J., Elkon R., Rechavi G., Michaelson D.M. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascade. Neurobiol. Dis. 2005, 20:709-718.
12. Puglielli L., Tanzi R.E., Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 2003, 6:345-351.
13. Risner M.E., Saunders A.M., Altman J.F., Ormandy G.C., Craft S., Foley I.M., Zvartau-Hind M.E., Hosford D.A., Roses A.D. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 2006, 6:246-254. Rosiglitazone in Alzheimer's disease study group.
14. Sastre M., Dewachter I., Rossner S., Bogdanovic N., Rosen E., Borghgraef P., Evert B.O., Dumitrescu-Ozimek L., Thal D.R., Landreth G., Walter J., Klockgether T., van Leuven F., Heneka M.T. Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:443-448.
15. Sauder S., Kölsch H., Lütjohann D., Schulz A., von Bergmann M., Maier W., Heun R. Influence of peroxisome proliferators-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. J. Neural Transm. 2005, 112:1381-1389.
16. Scacchi R., Pinto A., Gambina G., Rosano A., Corbo R.M. The peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians. Brain Res. 2007, 1139:1-5.
17. Shobab L.A., Hsiung G.Y., Feldman H.H. Cholesterol in Alzheimer's disease. Lancet Neurol. 2005, 4:841-852.
18. van Neerven S., Kampmann E., Mey J. RAR/RXR and PPAR/RXR signalling in neurological and psychiatric diseases. Prog. Neurobiol. 2008, 85:433-451.
19. West N.A., Haan M.N., Morgenstern H. The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study. Neurobiol. Aging 2008, 10.1016/j.neurobiolaging.2008.06.005.
20. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease: a double-edged sword. Neuron 2002, 35:419-432.
21. Xiong H., Callaghan D., Jones A., Walker D.G., Lue L.F., Beach T.G., Sue L.I., Woulfe J., Xu H., Stanimirovic D.B., Zhang W. Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production. Neurobiol. Dis. 2008, 29:422-437.
22. Yaffe K., Kanaya A.M., Lindquist K., Hsueh W.C., Cummings S.R., Beamer B., Newman A., Rosano C., Li R., Harris T. PPAR-γ Pro12Ala genotype and risk of cognitive decline in elders. Neurobiol. Aging 2008, 29:78-83. Health ABC Study.